Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:

Similar presentations


Presentation on theme: "Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:"— Presentation transcript:

1 Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial  Prof David Goldblatt, MBChB, Jo Southern, PhD, Nick J Andrews, PhD, Polly Burbidge, BSc, Jo Partington, BSc, Lucy Roalfe, BSc, Marta Valente Pinto, MD, Vasilli Thalasselis, Emma Plested, Hayley Richardson, BSc, Matthew D Snape, MBChB, Prof Elizabeth Miller, FRCPath  The Lancet Infectious Diseases  Volume 18, Issue 2, Pages (February 2018) DOI: /S (17) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

2 Figure Consort details
The Lancet Infectious Diseases  , DOI: ( /S (17) ) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions


Download ppt "Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:"

Similar presentations


Ads by Google